Author:
Mahdavi Manijeh,Keyhanfar Mehrnaz,Jafarian Abbas,Mohabatkar Hassan,Rabbani Mohammad
Publisher
Springer Science and Business Media LLC
Reference47 articles.
1. Correa I, Plunkett T. Update on HER-2 as a target for cancer therapy HER2/neu peptides as tumour vaccines for T cell recognition. Breast Cancer Res. 2001;3:399–403.
2. Carter PJ. Potent antibody therapeutics by design. Nat Rev Immunol. 2006;6:343–57.
3. Jager D, Knuth A. Antibodies and vaccines—hope or illusion? Breast. 2005;14:631–5.
4. Milani A, Sangiolo D, Montemurro F, Aglietta M, et al. Active immunotherapy in HER2 overexpressing breast cancer: current status and future perspectives. Ann Oncol. 2013;24(7):1740–8.
5. Garrett JT, Kaumaya P, Pei D, Dalbey R et al (2007). Peptide based B cell epitope vaccines targeting HER-2/Neu. Dissertation, Ohio State University
Cited by
9 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献